Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial).

Autor: Verry C; Radiotherapy Department, Grenoble Alps University Hospital, Grenoble, France; INSERM UA7, University of Grenoble Alps, Synchrotron Radiation for Biomedical Research (ESRF), Grenoble, France. Electronic address: cverry@chu-grenoble.fr., Dufort S; NH TherAguix SA, Meylan, France., Villa J; Radiotherapy Department, Grenoble Alps University Hospital, Grenoble, France., Gavard M; Clinical Research Vigilance, Grenoble Alps University Hospital, Grenoble, France., Iriart C; Radiotherapy Department, Grenoble Alps University Hospital, Grenoble, France., Grand S; Neuroradiology Department, Grenoble Alps University Hospital, Grenoble, France., Charles J; Dermatology Department, Grenoble Alps University Hospital, Grenoble, France., Chovelon B; Unit of Hormonal and Nutritional Biochemistry, Institute of Biology and Pathology, Grenoble Alps University Hospital, Grenoble, France., Cracowski JL; Clinical Investigation Center, Grenoble Alps University Hospital, Grenoble, France., Quesada JL; Clinical Investigation Center, Grenoble Alps University Hospital, Grenoble, France., Mendoza C; Clinical Investigation Center, Grenoble Alps University Hospital, Grenoble, France., Sancey L; Institute Light and Matter, UMR5306, Lyon1 University-CNRS, Lyon University, Villeurbanne, France., Lehmann A; Pharmacy Department, Grenoble Alps University Hospital, Grenoble, France., Jover F; Radiotherapy Department, Grenoble Alps University Hospital, Grenoble, France., Giraud JY; Radiotherapy Department, Grenoble Alps University Hospital, Grenoble, France., Lux F; Institute Light and Matter, UMR5306, Lyon1 University-CNRS, Lyon University, Villeurbanne, France., Crémillieux Y; NH TherAguix SA, Meylan, France; Institut des Sciences Moléculaires, UMR5255, Université de Bordeaux, France., McMahon S; Center for Cancer Research and Cell Biology, Queen's University Belfast, United Kingdom., Pauwels PJ; Dap-Santé Consulting, Dolomieu, France., Cagney D; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA., Berbeco R; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA., Aizer A; Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA., Deutsch E; Radiation Oncology Department, INSERM1030 Molecular Radiotherapy and Therapeutic Innovations, Paris-Saclay University, Gustave Roussy, Villejuif, France., Loeffler M; NH TherAguix SA, Meylan, France., Le Duc G; NH TherAguix SA, Meylan, France., Tillement O; Institute Light and Matter, UMR5306, Lyon1 University-CNRS, Lyon University, Villeurbanne, France., Balosso J; Radiotherapy Department, Grenoble Alps University Hospital, Grenoble, France.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2021 Jul; Vol. 160, pp. 159-165. Date of Electronic Publication: 2021 May 05.

Molecular cloning, pharmacological properties and tissue distribution of the porcine 5-HT1B receptor

Autor: Bhalla, P (Pankaj), Sharma, HS (Hari), Ma, X, Wurch, T, Pauwels, PJ, Saxena, Pramod

Publikováno v: British Journal of Pharmacology, 133, 891-901. Wiley-Blackwell

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::9c1322c5f806b8d79e1926d1e3517a6e
https://pure.eur.nl/en/publications/1fe0fdf5-2929-438c-96c1-347e00476de8

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.